Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage

NCT00890656 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Cyclophosphamide (CTX)
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Decadron
DRUG: G-CSF
DRUG: Methotrexate (MTX)
DRUG: Ara-C
DRUG: Pegaspargase

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]